Pan Cancer T is presenting preclinical data at CIMT and SITC 2023
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
23 februari 2023Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
12 mei 2023Dora Hammerl, PCT’s co-founder and VP R&D will present preclinical data on their lead program PCT1 focusing on target and TCR identification.
Link to poster: PCT1 poster SITC2023